Protagenic Therapeutics, Inc.\new Quarterly Current Ratio in % from Q1 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Protagenic Therapeutics, Inc.\new quarterly Current Ratio history and growth rate from Q1 2015 to Q2 2024.
  • Protagenic Therapeutics, Inc.\new Current Ratio for the quarter ending June 30, 2024 was 439 %, a 37% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 439 -258 -37% Jun 30, 2024
Q1 2024 488 -485 -49.9% Mar 31, 2024
Q4 2023 515 -687 -57.2% Dec 31, 2023
Q3 2023 543 -924 -63% Sep 30, 2023
Q2 2023 697 -802 -53.5% Jun 30, 2023
Q1 2023 973 -559 -36.5% Mar 31, 2023
Q4 2022 1.2K -57.1 -4.54% Dec 31, 2022
Q3 2022 1.47K +525 +55.7% Sep 30, 2022
Q2 2022 1.5K +959 +178% Jun 30, 2022
Q1 2022 1.53K +1.42K +1222% Mar 31, 2022
Q4 2021 1.26K +1.13K +877% Dec 31, 2021
Q3 2021 942 +834 +772% Sep 30, 2021
Q2 2021 539 +450 +504% Jun 30, 2021
Q1 2021 116 +49.3 +74.1% Mar 31, 2021
Q4 2020 129 +71.8 +126% Dec 31, 2020
Q3 2020 108 +50.4 +87.3% Sep 30, 2020
Q2 2020 89.3 +9.51 +11.9% Jun 30, 2020
Q1 2020 66.6 -43.9 -39.8% Mar 31, 2020
Q4 2019 57.1 -105 -64.9% Dec 31, 2019
Q3 2019 57.7 -178 -75.5% Sep 30, 2019
Q2 2019 79.8 -227 -74% Jun 30, 2019
Q1 2019 110 -253 -69.6% Mar 31, 2019
Q4 2018 163 -244 -60% Dec 31, 2018
Q3 2018 235 -208 -46.9% Sep 30, 2018
Q2 2018 307 -171 -35.7% Jun 30, 2018
Q1 2018 363 -163 -31% Mar 31, 2018
Q4 2017 406 -128 -24% Dec 31, 2017
Q3 2017 443 +25.7 +6.15% Sep 30, 2017
Q2 2017 478 +205 +75.1% Jun 30, 2017
Q1 2017 526 +360 +216% Mar 31, 2017
Q4 2016 535 +519 Dec 31, 2016
Q3 2016 417 +396 +1880% Sep 30, 2016
Q2 2016 273 +233 +587% Jun 30, 2016
Q1 2016 166 +117 +235% Mar 31, 2016
Q4 2015 15.2* Dec 31, 2015
Q3 2015 21.1 Sep 30, 2015
Q2 2015 39.7 Jun 30, 2015
Q1 2015 49.7 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.